BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schrage B, Uijl A, Benson L, Westermann D, Ståhlberg M, Stolfo D, Dahlström U, Linde C, Braunschweig F, Savarese G. Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score–Matched Analysis From the Swedish Heart Failure Registry. Circulation 2019;140:1530-9. [DOI: 10.1161/circulationaha.119.043012] [Cited by in Crossref: 41] [Cited by in F6Publishing: 10] [Article Influence: 13.7] [Reference Citation Analysis]
Number Citing Articles
1 Nauffal V, Marstrand P, Han L, Parikh VN, Helms AS, Ingles J, Jacoby D, Lakdawala NK, Kapur S, Michels M, Owens AT, Ashley EA, Pereira AC, Rossano JW, Saberi S, Semsarian C, Ware JS, Wittekind SG, Day S, Olivotto I, Ho CY. Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy. Eur Heart J 2021;42:3932-44. [PMID: 34491319 DOI: 10.1093/eurheartj/ehab598] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Holbrook R, Higuera L, Wherry K, Phay D, Hsieh YC, Lin KH, Liu YB. Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trial. PLoS One 2020;15:e0241697. [PMID: 33211698 DOI: 10.1371/journal.pone.0241697] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Markewitz A; Bundesfachgruppe Herzschrittmacher und Defibrillatoren. [Annual report 2017 of the German pacemaker- and defibrillator register - Part 2: implantable cardioverter defibrillators (ICD). : Working group on Cardiac pacemaker and implantable cardioverter-defibrillators at the IQTIG - Institute of Quality Assurance and Transparency in Healthcare]. Herzschrittmacherther Elektrophysiol 2019;30:389-403. [PMID: 31705261 DOI: 10.1007/s00399-019-00648-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
4 Yan I, Schrage B, Weimann J, Dabboura S, Hilal R, Beer BN, Becher PM, Seiffert M, Magnussen C, B Schnabel R, Kirchhof P, Blankenberg S, Westermann D. Sex differences in patients with cardiogenic shock. ESC Heart Fail 2021;8:1775-83. [PMID: 33763997 DOI: 10.1002/ehf2.13303] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Lund LH, Hage C, Savarese G. Implementation science and potential for screening in heart failure. Eur Heart J 2021:ehab751. [PMID: 34751776 DOI: 10.1093/eurheartj/ehab751] [Reference Citation Analysis]
6 Docherty KF, Jhund PS, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, DeMets DL, Sabatine MS, Bengtsson O, Sjöstrand M, Langkilde AM, Desai AS, Diez M, Howlett JG, Katova T, Ljungman CEA, O'Meara E, Petrie MC, Schou M, Verma S, Vinh PN, Solomon SD, McMurray JJV. Effects of dapagliflozin in DAPA-HF according to background heart failure therapy. Eur Heart J 2020;41:2379-92. [PMID: 32221582 DOI: 10.1093/eurheartj/ehaa183] [Cited by in Crossref: 65] [Cited by in F6Publishing: 51] [Article Influence: 65.0] [Reference Citation Analysis]
7 Mattsson G, Magnusson P. Long-term follow-up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality. Pacing Clin Electrophysiol 2020;43:245-53. [PMID: 31891421 DOI: 10.1111/pace.13869] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Vecchi AL, Abete R, Marazzato J, Iacovoni A, Mortara A, De Ponti R, Senni M. Ventricular arrhythmias and ARNI: is it time to reappraise their management in the light of new evidence? Heart Fail Rev 2020. [PMID: 32556671 DOI: 10.1007/s10741-020-09991-3] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Cho Y, Cho SY, Oh IY, Lee JH, Park JJ, Lee HY, Kim KH, Yoo BS, Kang SM, Baek SH, Jeon ES, Kim JJ, Cho MC, Chae SC, Oh BH, Choi DJ. Implantable Cardioverter-defibrillator Utilization and Its Outcomes in Korea: Data from Korean Acute Heart Failure Registry. J Korean Med Sci 2020;35:e397. [PMID: 33258331 DOI: 10.3346/jkms.2020.35.e397] [Reference Citation Analysis]
10 Yafasova A, Butt JH, Elming MB, Nielsen JC, Haarbo J, Videbæk L, Olesen LL, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Egstrup K, Gustafsson F, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S, Thune JJ, Køber L. Long-term Follow-up of the The Danish Study to Assess the Efficacy of ICDs in Patients with Non-ischemic Systolic Heart Failure on Mortality (DANISH). Circulation 2021. [PMID: 34882430 DOI: 10.1161/CIRCULATIONAHA.121.056072] [Reference Citation Analysis]
11 Jariwala P, Jadhav K, Punjani A, Boorugu H, Mari AR. ADDition of DAPAgliflozin, Sodium-Glucose Cotransporter-2 Inhibitor to Angiotensin Receptor Blocker-Neprilysin Inhibitors Non-Responders in Patient with Refractory Heart Failure with Reduced Ejection Fraction (ADD DAPA trial). Indian Heart J 2021;73:605-11. [PMID: 34627577 DOI: 10.1016/j.ihj.2021.07.005] [Reference Citation Analysis]
12 Lee JH, Yu HT, Oh IY, Choi EK, Sung JH, Lee YS, Kim JY, Baek Y, Park J, Joung B; ADVANCE-ICM investigators. Clinical and Hospital Factors Affecting Treatment with Primary Prevention Implantable Cardioverter-Defibrillators in Ischemic Cardiomyopathy Patients. Yonsei Med J 2020;61:942-50. [PMID: 33107237 DOI: 10.3349/ymj.2020.61.11.942] [Reference Citation Analysis]
13 Woolcott OO, Reinier K, Uy-Evanado A, Nichols GA, Stecker EC, Jui J, Chugh SS. Sudden cardiac arrest with shockable rhythm in patients with heart failure. Heart Rhythm 2020;17:1672-8. [PMID: 32504821 DOI: 10.1016/j.hrthm.2020.05.038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Israel CW, Tribunyan S. [Cardiac electrical device therapy in heart failure]. Dtsch Med Wochenschr 2020;145:1391-8. [PMID: 32971554 DOI: 10.1055/a-1061-0749] [Reference Citation Analysis]
15 Yao X, Lei W, Shi N, Lin W, Du X, Zhang P, Chen J. Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study. BMC Nephrol 2020;21:310. [PMID: 32727426 DOI: 10.1186/s12882-020-01909-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]